Cargando…
PCSK9 inhibition and cholesterol homeostasis in insulin producing β-cells
Low-density lipoprotein cholesterol (LDL-C) plays a central role in the pathology of atherosclerotic cardiovascular disease. For decades, the gold standard for LDL-C lowering have been statins, although these drugs carry a moderate risk for the development of new-onset diabetes. The inhibitors of pr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756761/ https://www.ncbi.nlm.nih.gov/pubmed/36527064 http://dx.doi.org/10.1186/s12944-022-01751-6 |